Loading insider details...
Beta
Latest Form 4 (Oct 6, 2026): Grant/Award of 200,000 ACHV shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | ACHIEVE LIFE SCIENCES, INC. (ACHV) | Grant/Award | 200,000 | n/a |
| Jul 13, 2026 | Esperion Therapeutics, Inc. (ESPR) | Disposition to Issuer | 705,410 | n/a |
| Jun 18, 2026 | Esperion Therapeutics, Inc. (ESPR) | Sale | 10,773 | $34.0K |
| Mar 18, 2026 | Esperion Therapeutics, Inc. (ESPR) | Sale | 6,424 | $17.4K |
| Mar 16, 2026 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 247,430 | n/a |
| Dec 18, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 7,337 | $26.9K |
| Sep 18, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 7,046 | $19.8K |
| Jul 18, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 11 | $12.27 |
| Jun 18, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 7,229 | $8.3K |
| Apr 21, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 8 | $7.71 |